Skip to main content
. 2016 Sep 8;14(1):51. doi: 10.1186/s12969-016-0111-7

Table 3.

genotype/phenotype correlation in DADA2

Mutation Exon N° of patients Associated symptoms (% of patients)
M1T 2 1 in heterozygosis Fever
Skin: Non-Langerhans cell histiocytosis
CNS/PNS: ischemic stroke
Visceral: involvement: hepatomegaly, splenomegaly. portal hypertension, hypertension (100 %)
K13del 2 2 in heterozygosis Fever (50 %)
Skin: Livedo racemosa (50 %), skin nodules (50 %)
Immune/hematologic system: hypogammaglobulinemia (100 %), recurrent infections (50 %)
28-kb-deletion 2 1 in heterozygosis Fever
Skin: Livedo reticularis, urticarial rash
CNS/PNS: ischemic and haemorrhagic strokes
Visceral involvement: hepatomegaly, splenomegaly. chronic gastritis
Immune/hematologic system: leukopenia, hypogammaglobulinemia (100 %)
G47R 2 27 in homozygosis Fever (64 %)
Skin: Livedo reticularis (60 %), skin nodules (35 %), ulcerations at extremities/digital necrosis (32 %), Raynaud’s phenomenon (28 %), purpuric/vasculitic rash (18 %), erythema nodosum (18 %), panniculitis (3 %)
CNS/PNS: ischemic stroke (21 %), hemorrhagic stroke (7 %), intracranial haemorrhage (11 %), cranial nerve paralysis (14 %), polineuropathy (11 %), neurosensorial hearing loss (3 %).
Visceral involvement: abdominal pain (21 %), intestinal vasculitis (14 %), hepatomegaly (3 %), splenomegaly (7 %), hypertransaminasemia (3 %), hypertension (25 %).
Immune/hematologic system: Leucopoenia (3 %), anaemia (3 %), lymphadenopathy (3 %).
1 in heterozygosis
G47A 2 2 in heterozygosis Fever (100 %)
Skin: Livedo reticularis (100 %), urticarial rash (100 %)
CNS/PNS: ischemic and haemorrhagic strokes (100 %)
Visceral involvement: hepatomegaly (100 %), splenomegaly (100 %), portal hypertension (100 %)
Immune/hematologic system: Pancytopenia (100 %), hypogammaglobulinemia (100 %).
G47V 2 1 in heterozygosis Fever
Skin: Livedo reticularis
Visceral involvement: hypertension, abdominal and renal aneurysm (100 %).
I93T 2 1 in heterozygosis Fever
Skin: Non-Langerhans cell histiocytosis
CNS/PNS: ischemic stroke
Visceral: involvement: hepatomegaly, splenomegaly. portal hypertension, hypertension (100 %)
A109D 3 1 in heterozygosis Fever
Skin: Livedo reticularis
CNS/PNS: ischemic stroke
Visceral involvement: splenomegaly (100 %).
H112Q 3 1 in heterozygosis Fever
Skin: Livedo reticularis, urticarial rash
CNS/PNS: ischemic and haemorrhagic strokes
Visceral involvement: hepatomegaly, splenomegaly, portal hypertension
Immune/hematologic system: Pancytopenia, hypogammaglobulinemia (100 %).
T119A 3 4 in heterozygosis Fever (100 %)
Skin: Livedo reticularis, ulceration of extremities (100 %)
CNS/PNS: ischemic and haemorrhagic strokes (100 %)
G142S 3 4 in heterozygosis Fever (100 %)
Skin: Livedo reticularis, ulceration of extremities (100 %)
CNS/PNS: ischemic and haemorrhagic strokes (100 %)
R169Q 3 15 in homozygosis Fever (37 %)
Skin: Livedo reticularis (58 %), skin nodules (4 %), ulcerations at extremities/digital necrosis (8 %), Raynaud’s phenomenon (8 %), purpuric/vasculitic rash (13 %), erythema nodosum (13 %), eczema (20 %)
CNS/PNS: ischemic stroke (54 %), hemorrhagic stroke (13 %), intracranial haemorrhage (13 %), cranial nerve paralysis (37 %), polineuropathy (8 %), neurosensorial hearing loss (8 %).
Visceral involvement: abdominal pain (17 %), bowel ulcerations (8 %), chronic gastritis (4 %), bowel stenosis (4 %), colitis (4 %), hepatomegaly (45 %), splenomegaly (58 %), acute liver failure (4 %), hypertension (8 %).
Immune/hematologic system: hypogammaglobulinemia (62 %), pancytopenia (8 %), leucopoenia (20 %), lymphopenia (13 %), granulocytopenia (4 %), anaemia (25 %), thrombocytopenia (4 %),
lymphadenopathy (25 %), recurrent infections (29 %).
9 in heterozygosis
P193L 4 1 in heterozygosis Fever
Skin: Livedo reticularis, ulcerations at extremities
CNS/PNS: ischemic stroke, TIA, intracranial haemorrhage, polineuropathy
Visceral involvement: bowel stenosis, oral aphtae
Immune/hematologic system: hypogammaglobulinemia (100 %).
M243R 4 2 in heterozygosis Fever (50 %)
Skin: erythema nodosum (50 %)
CNS/PNS: intracranial haemorrhage (50 %)
Visceral involvement: splenomegaly (100 %)
Immune/hematologic system: hypogammaglobulinemia (100 %), recurrent infections (100 %).
P251L 4 4 in heterozygosis Fever (25 %)
Skin: Livedo reticularis (75 %), vasculitic rash (50 %)
CNS/PNS: ischemic stroke (75 %), cranial nerve paralysis (100 %), neurosensorial hearing loss (25 %).
Visceral involvement: hypertension (25 %), epididymitis (25 %)
W264S 5 1 in heterozygosis Fever
Skin: Livedo reticularis
Visceral involvement: hypertension, abdominal and renal aneurysm (100 %).
R306* 6 1 in heterozygosis Fever
Skin: rash
CNS/PNS: ischemic stroke, hemorrhagic stroke, intracranial haemorrhage (100 %)
N328K 7 2 in heterozygosis Fever (50 %)
Skin: Livedo racemosa (50 %), skin nodules (50 %)
Immune/hematologic system: hypogammaglobulinemia (100 %), recurrent infections (50 %)
Y453C 9 3 in heterozygosis Fever (100 %)
Skin: Livedo reticularis (100 %), urticarial rash (33 %)
CNS/PNS: ischemic stroke (100 %), haemorrhagic strokes (33 %)
Visceral involvement: hepatomegaly (66 %), splenomegaly (100 %), portal hypertension (33 %)
Immune/hematologic system: Pancytopenia (66 %), hypogammaglobulinemia (66 %).